New England Journal of Medicine · 1965 · 20 citations · 10 references
PharmacyPharmacologyPharmacotherapyAntimicrobial PharmacotherapyAntimicrobial ResistanceClinical PharmacologyAntibacterial PharmacologyAntibacterial PharmacotherapyAntibiotic ResistanceMethicillin ResistanceMethicillin-resistant Staphylococcus Aureus TreatmentResistance Mechanisms In Staphylococci
NAFCILLIN, 6-(2-ethoxy-1-naphthamido) penicillin,1 is one of the semisynthetic, penicillinase-resistant penicillins that has been introduced since the isolation of 6-aminopenicillanic acid.2 Each of the newer penicillins in this series — namely, oxacillin, diphenicillin and nafcillin — has several readily apparent advantages over methicillin,3 the first one to become available for clinical use. Most important of these advantages are acid stability, permitting absorption of the drug when it is administered orally, and greater in vitro activity against both penicillinase-producing and nonpenicillinase-producing staphylococci. In addition, some data suggest that nafcillin may have greater therapeutic activity than methicillin or oxacillin in experimental infections in . . .
10
Synthesis of Penicillin: 6-Aminopenicillanic Acid in Penicillin Fermentations
F. R. Batchelor, F. P. Doyle, J. H. C. Nayler et al. · Nature · 1959 · 389 citations
Penicillinase-resistant Penicillins and Cephalosporins
Mary Barber, P. M. Waterworth · BMJ · 1964 · 97 citations · Full text
Jerome O. Klein, Theodore C. Eickhoff, Jeremiah G. Tilles et al. · The American Journal of the Medical Sciences · 1964 · 73 citations